Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 989 GBX 0.05% Market Closed
Market Cap: 4.4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Wall Street
Price Targets

HIK Price Targets Summary
Hikma Pharmaceuticals PLC

Wall Street analysts forecast HIK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIK is 2 361.81 GBX with a low forecast of 2 020 GBX and a high forecast of 3 255 GBX.

Lowest
Price Target
2 020 GBX
2% Upside
Average
Price Target
2 361.81 GBX
19% Upside
Highest
Price Target
3 255 GBX
64% Upside
Hikma Pharmaceuticals PLC Competitors:
Price Targets
FUM
Futura Medical PLC
336% Upside
SNT
Syntara Ltd
83% Upside
PPLPHARMA
Piramal Pharma Ltd
16% Upside
AQST
Aquestive Therapeutics Inc
214% Upside
326030
SK Biopharmaceuticals Co Ltd
22% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Hikma Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's revenue is 9%. The projected CAGR for the next 4 years is 6%.

9%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hikma Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's operating income is 6%. The projected CAGR for the next 4 years is 9%.

6%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Hikma Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's net income is -3%. The projected CAGR for the next 4 years is 35%.

-3%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HIK's stock price target?
Price Target
2 361.81 GBX

According to Wall Street analysts, the average 1-year price target for HIK is 2 361.81 GBX with a low forecast of 2 020 GBX and a high forecast of 3 255 GBX.

What is Hikma Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's revenue is 9%. The projected CAGR for the next 4 years is 6%.

What is Hikma Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's operating income is 6%. The projected CAGR for the next 4 years is 9%.

What is Hikma Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
35%

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's net income is -3%. The projected CAGR for the next 4 years is 35%.

Back to Top